Recalls from MYLAN PHARMACEUTICALS INC

• Mylan Mycophenolate Mofetil for Injection (opens in a new tab)
  Moderate risk, FDA, Sep 3, 2026, Drug dissolving problem
• Mylan Prasugrel Tablets (opens in a new tab)
  Moderate risk, FDA, Aug 28, 2026, Drug dissolving problem
• Mylan Acamprosate Calcium, Delayed-Release Tablets (opens in a new tab)
  Moderate risk, FDA, Aug 19, 2026, Drug dissolving problem
• Mylan Mycophenolate Mofetil for Injection (opens in a new tab)
  Moderate risk, FDA, Jul 24, 2026, Quality problem
• Mylan Amnesteem Isotretinoin Capsules (opens in a new tab)
  Moderate risk, FDA, Mar 4, 2026, Drug dissolving problem

Data: Recall Canary (opens in a new tab)